Human Akt1 (E17K Mutation) Antibody, R&D Systems™

AKT1

Monoclonal

LYOPH

Western Blot 0.5 ug/mL, Immunocytochemistry 8-25 ug/mL

P31749

AKT1

Synthetic peptide containing human Akt1 Ala5-Lys30 with Glu17Lys mutation Accession # P31749

25 μg

Primary

Detects human AKT1 with Glu17Lys mutation in Western blots. In Western blots, no cross-reactivity with 293-EBNA human EBV-expressing embryonic kidney cell line transfectant expressing wild type AKT1 is detected.

Human

Purified

Western Blot, Immunocytochemistry

710022

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

AKT, AKT serine/threonine kinase 1, AKT1m, CWS6, EC 2.7.11, EC 2.7.11.1, PKB, PKB alpha, PKBMGC99656, PRKBA, Protein kinase B, Protein Kinase B Alpha, Proto-oncogene c-Akt, RAC, rac protein kinase alpha, RAC-ALPHA, RAC-alpha serine/threonine-protein kinas

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

207

Sterile PBS to a final concentration of 0.5 mg/mL.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1